Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Godavari Drugs Limited has filed a statement confirming there are NO deviations or variations in how the funds from a preferential allotment of equity (raised on 18.03.2026 for Rs. 441.73 Lakhs) have been utilized during the quarter and year ended March 31, 2026. The company raised Rs. 441.73 Lakhs and allocated Rs. 1,000 Lakhs towards capital expenditure for setting up a manufacturing plant for active pharmaceutical ingredients and specialty chemicals at MIDC Nanded, Maharashtra. Another Rs. 171.73 Lakhs was for working capital requirements, and Rs. 1,600 Lakhs was planned for repayment of unsecured loans to promoters/directors. As the actual amount raised was lower than planned allocations, only a portion has been deployed so far. The Audit Committee reviewed and confirmed there is no deviation from the stated objects.
For shareholders, this is a routine compliance filing showing the company is deploying funds as promised. The shortfall in raised amount versus planned usage (Rs. 441.73 Lakhs raised vs. Rs. 2,771.73 Lakhs planned) means the company may need additional capital to fully execute its stated plans for the Nanded manufacturing facility.